Evolution of a CDC Public Health Research Agenda for Low-Risk XXXX .

@entity1 @entity263
UNASSIGNED: @entity1 with @entity263 face difficult choices when selecting a therapy for @entity263 . Comparative data from controlled studies are lacking and clinical opinions diverge about the benefits and harms of treatment options. Consequently, there is limited guidance for @entity1 regarding the impact of treatment decisions on quality of life. There are opportunities for public health to intervene at several decision-making points. Information on typical quality of life outcomes associated with specific @entity263 treatments could help @entity1 select treatment options. From 2003 to present, the Division of Cancer Prevention and Control at CDC has supported projects to explore @entity1 information-seeking behavior post-diagnosis, caregiver and provider involvement in treatment decision making, and @entity1 quality of life following @entity263 treatment. CDC's work also includes research that explores barriers and facilitators to the presentation of active surveillance as a viable treatment option and promotes equal access to information for @entity1 and their caregivers. This article provides an overview of the literature and considerations that initiated establishing a prospective public health research agenda around treatment decision making. Insights gathered from CDC-supported studies are poised to enhance understanding of the process of shared decision making and the influence of @entity1 , caregiver, and provider preferences on the selection of treatment choices. These findings provide guidance about attributes that maximize @entity1 experiences in survivorship, including optimal quality of life and @entity1 and caregiver satisfaction with information, treatment decisions, and subsequent care.
